Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAF(V600)-mutant advanced melanoma: a multicenter cohort study
在BRAF抑制剂靶向治疗的基础上加用抗PD-1免疫疗法可改善BRAF(V600)突变型晚期黑色素瘤患者的真实世界生存期并延缓脑转移:一项多中心队列研究
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70102
Wu, Junwan; Ding, Qiuyue; Zhang, Qiong; Chen, Qianqi; Wen, Xizhi; Ding, Ya; Li, Jingjing; Chen, Ziluan; Zhang, Tao; Wang, Jiuhong; Huang, Fuxue; Jiang, Hang; Chen, Linbin; Zhou, Qiming; Li, Ke; Zhang, Xiaoshi; Li, Dandan